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Abstract
Background: Vietnam has a smoking prevalence that is the second highest among Southeast Asian countries
(SEACs). According to the World Health Organization (WHO), most reductions in mortality from tobacco use in the
near future will be achieved through helping current users quit. Yet, largely due to a lack of research on strategies
for implementing WHO-endorsed treatment guidelines in primary care settings, services to treat tobacco dependence
are not readily available to smokers in low middle-income countries (LMICs) like Vietnam. The objective of this study is
to conduct a cluster randomized controlled trial that compares the effectiveness of two system-level strategies for
implementing evidence-based guidelines for the treatment of tobacco use in 26 public community health centers
(CHCs) in Vietnam.
Methods/Design: The current study will use a cluster-randomized design and multiple data sources (patient exit
interviews, provider and village health worker (VHW) surveys, and semi-structured provider/VHW interviews) to study
the process of adapting and implementing clinical practice guidelines in Vietnam and theory-driven mechanisms
hypothesized to explain the comparative effectiveness of the two strategies for implementation. CHCs will be
randomly assigned to either of the following: (1) training plus clinical reminder system (TC) or (2) TC + referral to a VHW
(TCR) for three in person counseling sessions. The primary outcome is provider adherence to tobacco use treatment
guidelines. The secondary outcome is 6-month biochemically verified smoking abstinence.
Discussion: The proposed implementation strategies draw on evidence-based approaches and a growing literature
that supports the effectiveness of integrating community health workers as members of the health care team to
improve access to preventive services. We hypothesize that the value of these implementation strategies is additive
and that incorporating a referral resource that allows providers to delegate the task of offering counseling (TCR) will
be superior to TC alone in improving delivery of cessation assistance to smokers. The findings of this research have
potential to guide large-scale adoption of promising strategies for implementing and disseminating tobacco use
treatment guidelines throughout the public health system in Vietnam and will serve as a model for similar action in
other LMICs.
Trial registration: NCT01967654
Keywords: Vietnam, Clinical practice guidelines, Treatment of tobacco dependence, Tobacco cessation
Background
Almost half of adult men in Vietnam are current smokers,
a smoking prevalence that is the second highest among
Southeast Asian countries (SEACs) [1]. If current smoking
rates are not addressed, it is estimated that in 10 years, to-
bacco use will be responsible for about 25 % of adult male
deaths in Vietnam [2]. Most reductions in mortality from
tobacco use in the near future will be achieved through
helping current users quit [3, 4]. Encouragingly, two thirds
of current smokers in Vietnam are planning to or thinking
about quitting and over half attempt to quit annually [1].
Tobacco use treatment, as defined by the U.S. Preventive
Health Service Guideline (PHS Guideline) on Treating
Tobacco use and Dependence, is evidence-based and highly
cost-effective [5]. The Guideline, which is endorsed by the
World Health Organization (WHO), is based on a meta-
analysis of over 8000 studies and provides strong evidence
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that asking all patients about tobacco use, advising
smokers to quit, assessing readiness, providing assistance,
and arranging follow-up (the 5As) can significantly in-
crease smoking abstinence rates [5]. Yet, adoption of
guideline-recommended care into routine public health
and clinical practice in low middle-income countries
(LMICs) is suboptimal [6, 7]. This is in large part due to a
lack of research on strategies for implementing evidence-
based tobacco use treatment guidelines.
Implementing evidence-based tobacco use treatment is
a core provision in the WHO Framework Convention
on Tobacco Control (FCTC). The FCTC is an evidence-
based treaty that was developed by the WHO in re-
sponse to the globalization of the tobacco epidemic [8].
The FCTC regulatory strategies include implementing
evidence-based smoking cessation treatment in public
health care delivery settings. In fact, Article 14 of the
FCTC states that “each country shall take effective mea-
sures to promote cessation and adequate treatment for
tobacco dependence” [9]. Although Vietnam has a strong
public health delivery system, according to the 2010
Global Adult Tobacco Survey, like other SEACs, services
to treat tobacco dependence are not readily available to
smokers [1]. Barriers to integrating treatment into rou-
tine primary care in LMICs are similar to those in the
USA and include the following: (1) inadequate training
of health care providers, (2) lack of evidence-based sys-
tems for implementing guideline recommended care,
and (3) a lack of research on strategies for implementing
tobacco use treatment guidelines in LMICs [10].
Closing the gap between research and practice is
stymied by limited research on cost-effective strategies
for integrating cessation services into routine practice.
Drawing upon a burgeoning implementation science
literature [11–17] and a growing literature that supports
the effectiveness of integrating community health wor-
kers as members of the health care team to improve
access to preventive services [18–24], we propose to
compare the effects of two organization-level strat-
egies: (1) training and a clinical reminder system (TC) vs.
(2) TC + referral (TCR) to community health workers
(CHW), referred to as village health workers (VHW) in
Vietnam, for additional counseling and support. The PHS
Guideline strongly recommends staff training and clinical
reminder systems as the foundation for increasing adher-
ence to guideline-recommended care [5]. However, several
studies have shown that adding a referral system can en-
hance rates of provider adherence to tobacco use treatment
guidelines and increase smoking abstinence rates beyond
that of training and clinical reminders alone [13–16]. The
impact of referral systems on adherence to tobacco use
treatment guidelines is also supported by a recent study in
Malaysia [25]. This study, conducted in diabetes clinics,
similarly found that providing a referral to stand-alone
cessation clinics motivated clinicians to routinely provide
cessation advice. Therefore, offering a referral option for
additional counseling may enhance quit attempts and ces-
sation rates. However, the Malaysian model of creating
stand-alone cessation clinics is too expensive to dissemin-
ate widely and stands in contrast to recommendations
from the WHO’s recently published guidelines for im-
plementing Article 14 which states: “In order to promote
tobacco cessation and develop tobacco dependence
treatment as rapidly as possible and at as low a cost as
possible, countries should use existing resources and
infrastructure” [9].
This proposal leverages existing infrastructure ele-
ments, including a robust public health care delivery sys-
tem with an extensive network of VHWs in Vietnam. In
Vietnam, as in other LMICs, VHWs have a strong track
record of effectively delivering preventive services and
increasing the reach of these programs [18, 20]. As a
critically important member of the public health care
system, it is surprising that in LMICs, there are no studies
evaluating the role of community health workers as a re-
ferral resource for increasing access to evidence-based
smoking cessation services, and we are aware of only one
study in the USA [19]. Consistent with WHO Guidelines
for implementing Article 14, CHWs offer a sustainable re-
source for ensuring wide access to support for tobacco
users who wish to quit. Using a two-arm cluster ran-
domized control trial design, the aims of this study are to
(1) compare the effectiveness and cost-effectiveness of two
multi-component strategies for implementing tobacco use
treatment guidelines and (2) use a mixed methods ap-
proach to explore potential theory-driven mechanisms




The Vietnamese health care system is hierarchically or-
ganized into four administrative levels: central, province,
district, and community. At the central level is the
Ministry of Health (MOH), the main national authority in
the health sector, which formulates and implements na-
tional health policies and programs. The provincial-level
health system consists of Provincial Health Departments
and Preventive Health Centers, which are administered by
the Provincial People’s Committee in each province. At
the district level, the District People’s Committee adminis-
ters district health centers and district-level hospitals.
Within districts, the community health centers (study sites
for this research) serve as the primary access point for
public health and preventive care services in Vietnam,
each providing services for an average of 3000–15,000
people in their surrounding community. CHCs are
charged with implementing more than 10 national health
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programs, treatment of common diseases, provision of
health counseling and education, referral services, pre-
and post-natal care, family planning, and food hygiene
and safety. Each CHC is staffed by 5–6 clinicians, includ-
ing 1 physician and 3–5 other health professionals (nurses,
midwives). In addition, each CHC is supported by a net-
work of 8–20 VHWs who provide counseling and educa-
tion to implement national health programs at the village
level and serve as clinician extenders to ensure patients
are adhering to clinician-recommended care. VHWs are
under the direct management and direction of the CHCs
and coordinate with community and social organizations
in the village.
Study design
We are conducting a two-arm, cluster randomized con-
trolled trial comparing (1) training and clinical reminder
system (TC) vs. (2) TC + referral to a VHW (TCR) for
additional counseling (Fig. 1). The primary outcome is im-
provement in provider adherence to tobacco use treat-
ment guidelines which has been found through extensive
meta-analysis to be an essential determinant of patient
cessation outcomes [5]. The secondary outcome is 6-
month biochemically verified smoking abstinence rates.
Finally, guided by Damschroeder’s Consolidated Frame-
work for Implementation Research and Weiner’s
organizational model of innovation implementation, we
will explore external (e.g., national and district level pol-
icy) and internal setting constructs (e.g., organizational
readiness) that may influence the relationship between the
implementation strategies and implementation effective-
ness [26–29].
Study site eligibility and recruitment
We are recruiting 26 health centers in Thai Nguyen, a
rural province north of Hanoi. Thai Nguyen has 9 dis-
tricts with 180 CHCs. Site criteria include having at least
one physician, ≥4 allied health care professional staff, ≥5
VHWs, and a patient population of at least 3000. Site
recruitment started with in-person site visits with the
Director of the District Health Centers to introduce the
study and to obtain a list of CHCs that fit these criteria.
Among those expressing interest, we randomly selected
26 CHCs. For practical reasons (cost and staffing), clinic
sites will be recruited in 3 successive waves with 8 in the
first wave, 10 in the second, and 8 in the third wave.
Conceptual framework
Our proposed study draws on the Consolidated Frame-
work for Implementation Research (CFIR) to inform the
analysis of factors that influence effective implementation
(i.e., provider adherence to tobacco use treatment guide-
lines) and Weiner’s model for implementation effective-
ness [26, 27, 29] (Fig. 2). Similar to the socio-ecologic
model, CFIR acknowledges that the effectiveness of inter-
ventions implemented within a health system is influenced
by the interaction of environmental/policy within the lar-
ger health care system in Vietnam, organizational (e.g.,
organizational readiness), and individual-level factors.
Therefore, CFIR organizes constructs into domains that
include (a) intervention characteristics, (b) outer setting,
(c) inner setting, and (d) individual (patient and provider)
characteristics. Wiener et al.’s model addresses “inner set-
ting” or organizational factors positing that implementa-
tion strategies (i.e., TC and TCR) enhance implementation
effectiveness through changes they produce in the
implementation climate (i.e., means, opportunity, and
expectation) and the extent to which providers perceive
that delivering guideline-concordant tobacco use treat-
ment fits their values (i.e., attitudes) and local task re-
quirements (e.g., workload and workflow). ARM 1 (TC) is
expected to promote a positive implementation climate by
enhancing providers’ perception that tobacco use treat-
ment is a priority and by providing the means (i.e., new
knowledge through training) for adhering to guideline-
recommended care. We hypothesize that the addition of a
VHW referral system (ARM 2) will result in rates of
provider adherence that are superior to ARM 1 through
additional changes in perceived means, opportunity, and
enhanced task fit (i.e., referral system offers providers’ an
opportunity to delegate counseling and follow-up).
Description of intervention conditions
ARM 1: provider and staff training and clinical reminder
system (TC)
Staff training All clinical and support staff will attend a 2-
day training in the use of the 5As and the intervention
protocol, including how to make a referral to the VHW (for
those in ARM 2). The training is based on the PHS
Fig. 1 Study design
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Guideline Treating Tobacco use and Dependence, the
WHO’s recently released training package for building cap-
acity for tobacco control in primary care and addresses core
competences defined by the Association for the Treatment
of Tobacco Use and Dependence (http://attudaccre-
d.org/) [5, 30]. Training will be conducted by Dr. Shel-
ley and Dr. Nguyen (MPIs). We will conduct pre- and
post-surveys to assess changes in knowledge and to assess
satisfaction with the training. A 1-day booster training will
be conducted at 3 months after the start of the interven-
tion to address challenges, review screening and counsel-
ing techniques, and review documentation procedures.
Clinical reminder system and toolkit The reminder
system is designed to remind the intake clinician to assess
smoking status, assess readiness, and offer each smoker
brief cessation counseling. Given the lack of charts in the
CHCs, this component of the intervention was adapted to
include posters prompting providers to ask about tobacco
use, advice patients to quit, and for sites in the referral
arm of the study, to refer patients to the VHW (Additional
file 1). Additional materials were developed as part of a lar-
ger toolkit to support provider and patient behavior change.
These include a table tent provides guidance for providers
on how to offer brief counseling and three-patient self-help
brochures (dangers of secondhand smoke, health effects of
smoking, and creation of a quit plan).
ARM 2: TC + referral to VHW
Referral to VHW Based on our pilot research, we cre-
ated a referral form that is similar to the one we have
tested in the USA [16, 17]. For smokers who are interested
in quitting and agree to be referred for counseling, the
form is completed by the CHC staff. VHWs will then pick
up the forms at their regular weekly meetings at the
CHCs. Smokers will be contacted within 5 days of their
visit to schedule the first of three counseling sessions. The
sessions are conducted in person and will last approxi-
mately 30 min. The first session will be conducted within
1 week of the patient visit to the CHC (planning session)
and the second and third sessions at 2 (within 2 days of
quit date) and 4 weeks post-clinic visit. The counseling
schedule is based on the PHS Guideline, our pilot data,
and evidence that early more intensive contact around the
quit date is associated with improved cessation rates
[5, 31, 32]. Counseling will focus on motivational barriers
for treatment readiness and offer stage-based cessation ad-
vice. Motivational interviewing (MI) techniques have been
found to be effective in increasing abstinence and quitting
attempts [33]. There is also evidence that lay health
workers can be trained to offer effective MI [34]. Six
VHWs from each intervention clinic will be invited to par-
ticipate in a 4-day training that will build on the provider
training to ensure proficiency in motivational techniques.
The MI module was adapted from an existing curriculum
and pretested in two focus groups with VHWs. Standard-
ized training, setting performance criteria, and conducting
a booster session will help ensure intervention fidelity. In
addition, each VHW will have a field manual, which will
have all of the information necessary for completion of
the intervention components as well as a checklist to
complete for each patient interaction. VHWs will receive
ongoing supervision by means of bimonthly meetings with
trained research staff and will attend a 1-day booster train-
ing session 2 months after the intervention begins to
minimize drift in counseling skills. Typically, we audiotape
counseling sessions to assess fidelity. However, in this
setting, we will adapt an approach used by the Vietnam
research for previous studies. At the start of each week,
VHWs will provide a schedule of home visits to the
research assistant (RA). The RA will observe a random se-
lection of the counseling sessions and document delivery
of essential components of the VHW protocol using a
standardized scoring sheet.
Evaluation plan
Mixed methods (i.e., qualitative interviews and survey)
data will be collected from patients, providers, and VHWs.
The evaluation plan is organized according to the follow-
ing domains: primary outcome, secondary outcome, cost,
baseline organization-level moderators, implementation
process measures, and implementation fidelity.
Fig. 2 Conceptual framework
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Outcome evaluation (AIM 1)
Primary outcome
To assess the primary outcome of provider adherence to
tobacco treatment guidelines, we will conduct patient
exit interviews (PEI) (surveys conducted immediately
after the patient visit) with 50 smokers pre- and 50 post-
implementation at each site (1300 in each study period)
(Additional file 1) [35–38]. The PEI, completed immedi-
ately after the visit, assesses the full spectrum of PHS
Guideline recommended care (i.e., 5As). It has well-
established validity as evidenced by strong correlation
with more costly audiotaped assessment of physician-
patient interactions [35]. Prior to and approximately
12 months following each site’s enrollment, consecutive
patients will be screened in the waiting area prior to
seeing their provider, to determine smoking status and to
obtain consent for the exit interview. The PEI will also as-
sess readiness to quit and patient demographics. Patients
are eligible to complete a PEI if they are (1) age 18 or over,
(2) at the CHC for a routine patient visit, and (2) active
smokers (current smoking within the past 7 days).
Secondary outcome
All patients who complete a PEI in the pre- and post-
intervention period will be followed prospectively to assess
3- and 6-month 7-day point prevalence abstinence, de-
fined as any smoking (even a puff) in the past 7 days [39].
Surveys will be conducted in person and smoking abstin-
ence will be validated using carbon monoxide (CO) moni-
toring with abstinence defined as a CO < 10 ppm.
Cost analysis
Cost measures include implementation costs (e.g., VHW,
system changes), patient time costs, and medical costs
including model-estimated impacts on downstream costs
attributable to tobacco-related illness (e.g., myocardial in-
farction). Health care and staff salary cost estimates will be
derived from Vietnamese health ministry officials. Imple-
mentation costs will include health professional time re-
quirements (including training of clinicians and VHWs),
major constituents of the VHW intervention, and patient
and provider materials. Incremental patient costs will be
assessed by surveying additional patient time required by
the VHW, as well as any indirect costs that are required
(e.g., elder or child care). Effectiveness inputs for the simula-
tion will arise from AIM 1 and will include 6-month smok-
ing abstinence and changes in health-related quality of life
as measured by the EQ-5D which has been translated into
Vietnamese [40]. We will explore variable assumptions
regarding the persistence of abstinence (e.g., relapse) in sen-
sitivity analyses. Estimates regarding baseline disease inci-
dence of chronic lung disease, lung cancer, and myocardial
infarction, as well as lifetables describing all-cause mortality
stratified by sex will be based on Vietnamese data.
Baseline organizational characteristics
Organizational structure and organizational readiness
to change At baseline, we are collecting data on
organizational variables including number of FTE staff,
staff characteristics, and clinic volume [28, 41]. We have
also adapted a tool developed by Weiner et al., to assess
baseline organizational readiness to implement practice
guidelines [42]. These measures will be assessed using
baseline surveys of medical directors at each CHC.
Implementation process evaluation (AIM 2)
We will use a mixed methods approach to assess outer set-
ting (i.e., policies and resources) and inner setting con-
structs (e.g., climate, resources to support implementation,
relative priority) that have been hypothesized to impact im-
plementation outcomes. We have adapted a survey tool de-
veloped by Weiner et al., to assess implementation climate,
and will use a measure developed by Solberg et al., to
assess relative priority for implementing tobacco use treat-
ment into routine practice [27, 43]. Baseline and post-
intervention surveys (12 months) administered to clinical
staff will assess these constructs. We will also conduct
post-implementation semi-structured interviews with a
sample of study staff participants in each site (2 VHWs, 3
providers, and 1 Medical Director) to further explore po-
tential barriers and facilitators for tobacco use treatment as
defined by CFIR. These include MOH policies, resources
(staffing, funding, training), perceptions about the inter-
vention (relative advantage, complexity), and beliefs about
their own and their colleagues’ ability to provide effective
tobacco use treatment (i.e., self and collective efficacy). The
interview guides will also include questions about the
process of integrating and customizing the implementation
strategy into the CHC workflow as well as acceptability
and potential for sustainability.
Implementation fidelity
We will use several approaches to evaluate the extent to
which each component of the implementation strategies
was delivered as intended.
Training and clinical reminder systems RAs will con-
duct site visits at 2, 6, and 12 months to document
(using a checklist) that the reminder and referral systems
and other components of the toolkit (e.g., self-help bro-
chures) materials are present and visible in the CHCs.
We will record the percentage of staff that attends train-
ings, as well as any changes in staffing, and we will con-
duct brief pre- and post-training assessments.
Referral system We will track the number of completed
referral forms. We will measure the percentage of pa-
tients referred that were reached by the VHW and the
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number of contacts VHWs made with each patient con-
tacted using VHW logs.
Analysis plan
AIM 1
The primary outcome will be evaluated using mixed-
effects regression analysis to estimate the difference be-
tween treatment conditions adjusting for the clustering
effects across multiple levels (patients, providers, clinics)
of the hierarchical data structure [44]. Treatment condi-
tion differences after the intervention period will be ex-
amined by creating a dummy variable for study arm with
the TC condition as a reference category. The fixed-
effects coefficient for treatment condition will contrast
TCR and TC alone conditions after the intervention
period. Covariates such as baseline organizational factors
(guideline adherence, FTEs) and urban vs. rural site will
be considered for inclusion in the mixed-effects model
to reduce the within-group variance, if they are predict-
ive of the primary outcome. A complex error term will
be specified with intercepts randomly varying across
sites and providers within sites. The secondary outcome
is smoking cessation, a binary variable (scored 1 = Yes,
0 = No). We will conduct an intent-to-treat analysis (i.e.,
those lost to follow-up considered smokers). The basic
model again involves a comparison of the two implemen-
tation strategies (TC vs. TCR). The binary outcome will be
modeled by a generalized linear mixed-effects model simi-
lar to what was described above for the primary outcome
[44]. A binomial family distribution and logit link will be
used. Exponentiating the fixed-effects coefficient for treat-
ment condition will generate an estimate of the odds ratio
(i.e., the effect of treatment condition on the odds of pa-
tient smoking cessation).
Power
For the primary outcome, optimal design [45] was used
to estimate power to detect an effect size of one stand-
ard deviation. We assume 10 patients per clinician, 5 cli-
nicians per site, and, conservatively, 33 % variance (i.e.,
the intra class correlation or ICC) at each level (site,
clinician, patient). With 26 sites and assuming a two-
sided type-1 error of 0.05, power is approximately 0.95
to detect this effect size. Optimal design was also used
to estimate power for the secondary outcome, where an
odds ratio of 2.3 is expected (13 % vs. 26 % abstinence
for TC and TCR conditions, respectively) [5]. We as-
sume a plausible interval for the smoking cessation rate
among patients in the TC alone condition ranging from
0.01 to 0.25, and we assume conservatively that 50 % of
the variability in cessation rates is between clinicians.
With 26 sites, we have 80 % power to detect the esti-
mated effect size.
Cost-effectiveness analysis (CEA): We will estimate the
incremental cost-effectiveness (ICER) of ARM 2 com-
pared to ARM 1 which is defined as the incremental
change in costs divided by the incremental change in ef-
fectiveness (e.g., QALYs with TCR minus QALYs with
TC alone). “QALY” refers to quality-adjusted life expect-
ancy and is a quantitative measure that simultaneously
takes into account both quality and quantity of life. We
will use measures of effect based on analyses from this
study combined with mathematical modeling to inform
the derivation of the cost and QALY estimates over lon-
ger time horizons than those over which data will be
collected (5-year, 10-year, 20-year, and lifetime horizons).
Downstream impact of TCR on future costs and benefits
(e.g., the downstream health impact of averting chronic
lung disease, as well as the downstream costs averted by
preventing those diseases) will be assessed via mathem-
atical modeling using a Markov (“state-transition”) com-
puter simulation that will enable attribution of the
health benefit that would be caused by specified reduc-
tions in smoking [46–49]. We will perform the analysis
from both a societal perspective and from a payer per-
spective [50].
AIM 2
For quantitative analysis, mixed-effects models for AIM 2
will be expanded to include additional main and inter-
action effects. A mixed-effects model also will be esti-
mated for implementation climate and fit with providers’
values and tasks, to determine whether treatment condi-
tions were different on the hypothesized mediators. These
hypothesized mediators also will be added to the models
for AIM 2, to determine whether climate and fit with pro-
viders’ values and tasks have unique effects on outcomes,
after controlling for treatment condition and covariates.
Baron and Kenny’s [51] causal-steps test can be applied to
explore if the impact of implementation strategies on
guideline adherence operates through implementation cli-
mate and/or innovation fit. Multilevel structural equation
modeling also will be employed to estimate indirect effects
of treatment condition on guideline adherence [52–55].
Effect modification by baseline site (i.e., organizational
readiness) characteristics will be explored by adding inter-
action effects between potential modifiers and treatment
condition. Qualitative data obtained from the audio re-
cordings of the semi-structured interviews and focus
groups will be transcribed verbatim in Vietnamese by
ISMS and then translated into English. Investigators’
fluency in English and Vietnamese will address concerns
about ensuring “conceptual equivalence” [56, 57]. A cod-
ing manual will be developed and finalized in an iterative
process. All transcripts will then be independently coded
by two members of the research team to establish inter-
rater reliability.
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Ethical review
The New York University School of Medicine and ISMS
Institutional Review Boards have approved the study.
Trial status
Funded in September 2013, in year 1, we finalized the
training curriculum and provider/VHW training plan,
finalized toolkit materials including the self-help bro-
chures and clinical reminder system (poster and table
tents), and finalized the survey tools and evaluation plan.
We have recruited all 26 CHCs and completed baseline
assessment for Wave 1 in August 2014. The baseline as-
sessment included collecting 398 PEIs, completing surveys
with 50 clinical providers and 147 VHW, and semi-
structured interviews with 40 providers and VHWs (5 at
each CHC). The Wave 1 intervention period started with
the provider and VHW trainings in September 2014. Con-
sistent with the protocol, 12-month post-intervention PEIs
will be completed in October 2015. Wave 2 (10 CHCs)
was launched in July 2015 and to date we have completed
401 baseline PEIs.
Discussion
Tobacco use continues to be the leading global cause of
preventable deaths. Of the world’s 1.25 billion adult
smokers, 10 % reside within SEACs [58]. Therefore, it is
critical to develop strategies for increasing access to
evidence-based tobacco use treatment services that
could lead to significant reductions in tobacco-related
morbidity and mortality. The WHO, through the FCTC,
has started to take action to reduce the burden of
tobacco-related disease in LMICs [8]. Treatment of to-
bacco use is mandated in Article 14 of the WHO FCTC
as a key component of comprehensive tobacco control
strategy. Tobacco dependence treatment is also recom-
mended by the WHO as part of a comprehensive pack-
age of essential services for prevention and control of
non-communicable diseases (NCDs) in primary care in
accordance to the revised draft of the WHO Global
Action Plan for the Prevention and Control of NCDs
(2013–2020). Yet, there are tremendous gaps in know-
ledge regarding how to implement guidelines for tobacco
use treatment in public health systems in LMICs. We
are not aware of any research that has attempted to
systematically study strategies for implementing tobacco
use treatment guidelines as a routine part of care pri-
mary care in LMICs. The current study has the potential
to provide relevant information to guide large-scale
adoption of strategies for implementing and disseminat-
ing tobacco use treatment guidelines throughout the
public health system in Vietnam and to serve as a model
for similar action in other LMICs and the U.S.
There are some potential limitations. First, we have
defined the core elements of the implementation
strategies; however, we acknowledge that adaptations to
the unique practice context will be necessary. We will
use fidelity checks to ensure that the core elements are
implemented and will document adaptations to enhance
external validity. Second differences between high-income
and low-income health care systems, including the high
smoking rates among male physicians, may pose chal-
lenges for implementation. However, our pilot research,
which is consistent with national surveys, found that
smoking rates among women (nurses and doctors) is less
than 5 % [1]. Over 70 % of providers working in CHCs
and 90 % of VHWs are female, somewhat mitigating this
potential problem. Finally, cessation medication is not
available in Vietnam; however, there is good evidence that
brief counseling alone from a physician or other health
care professional can increase abstinence rates by 30 %
and more intensive counseling, even without medication,
can result in quit rates of >20 % at 6 months compared to
less than 5 % without treatment [8]. In order to test the
impact of an intervention that would have the most po-
tential for sustainability, we are not providing cessation
pharmacotherapy.
Despite limitations, the findings have potential for high
impact by identifying best practices for implementing to-
bacco use treatment in public health care delivery sys-
tems in Vietnam and other LMICs and providing key
stakeholders with the data they need to make decisions
regarding dissemination of effective tobacco dependence
treatment guidelines.
Additional file
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